Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Joseph Imperato's publication output changed over time?
ScholarIQpublication output · 2020–2026
Output declined67% over the shown period — from 3 works in 2020 to 1 in 2026.
3
1
1
1
3
1
1
2020202120222023202420252026
What are the most-cited papers on Joseph Imperato?
ScholarIQmost cited works
<p>Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications</p>
Kelly H. Zou, Jim Z. Li, Joseph Imperato, Chandrashekhar Potkar, Nikuj Sethi, Jon Edwards, Amrit Ray
Journal of Multidisciplinary Healthcare. 202033 CitationsOPEN ACCESS
New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review
Tarek A. Hassan, Jorge Enrique Sáenz, Danutė Dučinskienė, Joseph P. Cook, Joseph Imperato, Kelly H. Zou
Journal of Multidisciplinary Healthcare. 202125 CitationsOPEN ACCESS
Harnessing real-world evidence to reduce the burden of noncommunicable disease: health information technology and innovation to generate insights
Kelly H. Zou, Jim Z. Li, Lobna A. Salem, Joseph Imperato, Jon Edwards, Amrit Ray
S24290265. 202013 CitationsOPEN ACCESS
Clinical Practice Management of Primary Open-Angle Glaucoma in the United States: An Analysis of Real-World Evidence
Joseph Imperato, Kelly H. Zou, Jim Z. Li, Tarek A. Hassan
Patient Preference and Adherence. 20227 CitationsOPEN ACCESS
COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US
Fernando J. Martínez, Alberto Papi, Tobias Welte, Dave Singh, Dmitry Galkin, Alessandro Guasconi, Stefania Pirondi, George Georges, Joseph Imperato, Ruben Hermans
International Journal of COPD. 20246 CitationsOPEN ACCESS
Related on ScholarIQ
IQVIA (United States)
Institution
<p>Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications</p>
Paper
New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review
Paper
Harnessing real-world evidence to reduce the burden of noncommunicable disease: health information technology and innovation to generate insights
Paper
Clinical Practice Management of Primary Open-Angle Glaucoma in the United States: An Analysis of Real-World Evidence
Paper
COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US
Paper